Helsinki, Finland-based Kaiku Health, which offers digital patient monitoring and patient-reported outcome services designed for several medical specialties, has announced $5.4 million (4.4 million euros) in Series A financing. The round was led by Debiopharm Innovation Fund SA and Tesi, with additional participation from new investor Prodeko Ventures and returning supporters Reaktor Ventures, Metsola Ventures, and Athensmed.

Source: Click here

Facebook Comments